TLPH insider transaction filings
TALPHERA, INC. — 38 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-24. Screen TLPH transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-24 | 4 | JAIN ABHINAV — Director | Grant/award (A): 5,100 @ $0 · Grant/award (A): 30,700 (derivative) @ $0 | EDGAR |
| 2026-06-24 | 4 | Bozilenko Marina — Director | Grant/award (A): 5,100 @ $0 · Grant/award (A): 30,700 (derivative) @ $0 | EDGAR |
| 2026-06-24 | 4 | Todisco Joseph — Director | Grant/award (A): 5,100 @ $0 · Grant/award (A): 30,700 (derivative) @ $0 | EDGAR |
| 2026-06-24 | 4 | Broadfoot Jill Marie — Director | Grant/award (A): 5,100 @ $0 · Grant/award (A): 30,700 (derivative) @ $0 | EDGAR |
| 2026-06-24 | 4 | ADAMS ADRIAN — Director | Grant/award (A): 5,100 @ $0 · Grant/award (A): 30,700 (derivative) @ $0 | EDGAR |
| 2026-06-24 | 4 | WAN MARK A — Director | Grant/award (A): 5,100 @ $0 · Grant/award (A): 30,700 (derivative) @ $0 | EDGAR |
| 2026-06-24 | 4 | HOFFMAN STEPHEN J — Director | Grant/award (A): 5,100 @ $0 · Grant/award (A): 30,700 (derivative) @ $0 | EDGAR |
| 2026-05-21 | 4 | Aslam Shakil — Chief Medical Officer | Tax withholding (F): 4,518 @ $0.82 | EDGAR |
| 2026-04-03 | 4 | Aslam Shakil — Chief Medical Officer | Tax withholding (F): 2,118 @ $0.72 | EDGAR |
| 2026-04-03 | 4 | Angotti Vincent J. — CHIEF EXECUTIVE OFFICER, Director | Tax withholding (F): 9,938 @ $0.72 | EDGAR |
| 2026-04-03 | 4 | ASADORIAN RAFFI — Chief Financial Officer | Tax withholding (F): 2,444 @ $0.72 | EDGAR |
| 2026-04-03 | 4 | Dasu Badri N — Chief Engineering Officer | Tax withholding (F): 2,444 @ $0.72 | EDGAR |
| 2026-03-25 | 4 | Angotti Vincent J. — CHIEF EXECUTIVE OFFICER, Director | Purchase (P): 213,310 @ $0.59 | EDGAR |
| 2026-03-17 | 4 | Nantahala Capital Management, LLC — 10% owner Harkey Wilmot B. — 10% owner Mack Daniel — 10% owner | Grant/award (A): 4,266,211 (derivative) @ $0.58 | EDGAR |
| 2026-02-20 | 4 | Aslam Shakil — Chief Medical Officer | Purchase (P): 35,000 @ $0.81 · Grant/award (A): 205,000 (derivative) @ $0 | EDGAR |
| 2026-02-20 | 4 | Angotti Vincent J. — CHIEF EXECUTIVE OFFICER, Director | Tax withholding (F): 3,179 @ $0.84 · Purchase (P): 105,364 @ $0.81 · Tax withholding (F): 9,559 @ $0.79 · Grant/award (A): 594,000 (derivative) @ $0 | EDGAR |
| 2026-02-20 | 4 | ASADORIAN RAFFI — Chief Financial Officer | Tax withholding (F): 958 @ $0.84 · Purchase (P): 45,000 @ $0.81 · Tax withholding (F): 2,933 @ $0.79 · Grant/award (A): 260,000 (derivative) @ $0 | EDGAR |
| 2026-02-20 | 4 | Dasu Badri N — Chief Engineering Officer | Tax withholding (F): 781 @ $0.84 · Purchase (P): 35,000 @ $0.81 · Tax withholding (F): 2,346 @ $0.79 · Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2025-10-24 | 4 | JAIN ABHINAV — Director | Grant/award (A): 4,267 @ $0 · Grant/award (A): 25,600 (derivative) @ $0 | EDGAR |
| 2025-10-24 | 4 | Bozilenko Marina — Director | Grant/award (A): 4,267 @ $0 · Grant/award (A): 25,600 (derivative) @ $0 | EDGAR |
| 2025-10-24 | 4 | Broadfoot Jill Marie — Director | Grant/award (A): 4,267 @ $0 · Grant/award (A): 25,600 (derivative) @ $0 | EDGAR |
| 2025-10-24 | 4 | ADAMS ADRIAN — Director | Grant/award (A): 4,267 @ $0 · Grant/award (A): 25,600 (derivative) @ $0 | EDGAR |
| 2025-10-24 | 4 | WAN MARK A — Director | Grant/award (A): 4,267 @ $0 · Grant/award (A): 25,600 (derivative) @ $0 | EDGAR |
| 2025-10-24 | 4 | HOFFMAN STEPHEN J — Director | Grant/award (A): 4,267 @ $0 · Grant/award (A): 25,600 (derivative) @ $0 | EDGAR |
| 2025-10-16 | 4 | Todisco Joseph — Director | Grant/award (A): 6,397 @ $0 · Grant/award (A): 38,381 (derivative) @ $0 | EDGAR |
| 2025-05-21 | 4 | Aslam Shakil — Chief Medical Officer | Tax withholding (F): 4,517 @ $0.52 | EDGAR |
| 2025-04-03 | 4 | Aslam Shakil — Chief Medical Officer | Grant/award (A): 15,000 @ $0 · Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2025-04-03 | 4 | ASADORIAN RAFFI — Chief Financial Officer | Grant/award (A): 15,000 @ $0 · Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2025-04-03 | 4 | Angotti Vincent J. — CHIEF EXECUTIVE OFFICER, Director | Purchase (P): 213,310 @ $0.59 · Grant/award (A): 61,000 @ $0 · Grant/award (A): 365,000 (derivative) @ $0 | EDGAR |
| 2025-04-03 | 4 | Dasu Badri N — Chief Engineering Officer | Grant/award (A): 15,000 @ $0 · Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Nantahala Capital Management, LLC — 10% owner Harkey Wilmot B. — 10% owner Mack Daniel — 10% owner | Grant/award (A): 4,266,211 (derivative) @ $0.58 | EDGAR |
| 2025-02-26 | 4 | Aslam Shakil — Chief Medical Officer | Purchase (P): 695 @ $0.98 · Purchase (P): 5,000 @ $1.07 | EDGAR |
| 2025-02-18 | 4 | ASADORIAN RAFFI — Chief Financial Officer | Tax withholding (F): 3,245 @ $0.67 | EDGAR |
| 2025-02-18 | 4 | Angotti Vincent J. — CHIEF EXECUTIVE OFFICER, Director | Tax withholding (F): 10,575 @ $0.67 | EDGAR |
| 2025-02-18 | 4 | Dasu Badri N — Chief Engineering Officer | Tax withholding (F): 2,644 @ $0.67 | EDGAR |
| 2025-02-12 | 4 | ASADORIAN RAFFI — Chief Financial Officer | Tax withholding (F): 1,059 @ $0.63 · Tax withholding (F): 1,060 @ $0.62 | EDGAR |
| 2025-02-12 | 4 | Angotti Vincent J. — CHIEF EXECUTIVE OFFICER, Director | Tax withholding (F): 3,515 @ $0.63 · Tax withholding (F): 3,517 @ $0.62 | EDGAR |
| 2025-02-12 | 4 | Dasu Badri N — Chief Engineering Officer | Tax withholding (F): 879 @ $0.63 · Tax withholding (F): 880 @ $0.62 | EDGAR |
Recent 8-K events — TALPHERA, INC.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-23 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-23 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-16 | 8-K | 3.02 — Unregistered Sales of Equity Securities | EDGAR |
| 2026-03-13 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2025-11-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-24 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-22 | 8-K | 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events | EDGAR |
| 2025-10-16 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=TLPH returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →